Search results for " bone"

showing 10 items of 933 documents

Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial.

2014

Abstract Background and aim Post-menopausal women are at higher risk of cardiovascular disease and bone demineralization. Phytosterols (PS) may be used for hypercholesterolemia in some groups and β-cryptoxanthin (β-Cx) displays a unique anabolic effect on bone. Our aim was to assess the changes in cardiovascular and bone turnover markers from the oral intake of β-Cx and PS in post-menopausal women. Methods and results A randomized, double-blind, crossover study with β-Cx (0.75 mg/day) and PS (1.5 g/day), single and combined, was performed in 38 postmenopausal women. Diet was supplemented with 1 × 250 mL milk-based fruit drink/day for 4 weeks with a wash-out period of 4-weeks in between. Ser…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismCampesterolOsteoporosisHypercholesterolemiaMedicine (miscellaneous)Parathyroid hormoneAdministration OralGastroenterologyBone and BonesBone remodelingchemistry.chemical_compoundDouble-Blind MethodRisk FactorsInternal medicineStatistical significancemedicineHumansCryptoxanthinsTriglyceridesAgedNutrition and DieteticsCross-Over StudiesDose-Response Relationship Drugbusiness.industryCholesterol HDLPhytosterolsCholesterol LDLMiddle Agedmedicine.diseaseCrossover studySitosterolsHealthy VolunteersClinical trialPostmenopauseEndocrinologyCholesterolTreatment OutcomechemistrySelective estrogen receptor modulatorCardiovascular DiseasesDietary SupplementsFemaleCardiology and Cardiovascular MedicinebusinessNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

A systematic review on regenerative alveolar graft materials in clinical trials

2021

Abstract Background Alveolar cleft grafting is a necessary procedure to restore bone defects. Randomized clinical trials (RCTs) are regarded as a golden standard for investigating the efficacy of treatments. Nevertheless, risk of bias (RoB) can still affect the validity of these trials. We aimed to conduct a systemic review of all control trials (CTs) using regenerative materials for alveolar cleft reconstructions to evaluate their RoB and perform a meta-analysis of new bone formation. Methods Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), EMBASE AND Google Scholar were searched up to October 2020. Thereafter, th…

medicine.medical_specialtyEvidence-based medicineMEDLINElaw.inventionIliumRandomized controlled triallawmedicineAdequacy of methodHumansTissue engineeringBone regenerationAutograftsIntention-to-treat analysisbusiness.industryEvidence-based medicineSDG 10 - Reduced InequalitiesRisk of biasJadad scaleSurgeryBone regenerationClinical trialCleft PalateMeta-analysisRegenerative medicine/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesSurgeryCell transplantationbusinessAlveolar bone graftingJournal of Plastic, Reconstructive and Aesthetic Surgery
researchProduct

Ultrasonography utilization in forearm fractures at the emergency department

2019

medicine.medical_specialtyForearm injurymedicine.diagnostic_testbusiness.industryMEDLINEForearm InjuriesGeneral MedicineEmergency departmentUlna FracturesSurgeryForearmFractures BoneEmergency trauma Fluoroscopy Forearm fractures Ultrasonographymedicine.anatomical_structureForearmEmergency MedicineHumansMedicineFluoroscopyUltrasonographyChildEmergency Service HospitalbusinessUlna FracturesUltrasonographyThe American Journal of Emergency Medicine
researchProduct

Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study

2006

None of the available osteoporosis therapies have been shown to completely abolish the risk of fractures. In clinical practice, the outcome may be even poorer. In 880 patients prescribed with antiresorptives (alendronate, risedronate, and raloxifene) for >1 year, a fragility fracture was recorded in 8.9%/year of them. This incidence is considerably higher than that observed in randomized clinical trials, and it was significantly related to poor compliance and lack of supplementation with calcium and vitamin D. Introduction: Osteoporotic fracture is one of the most important public health concerns among the elderly. Currently available therapies have been shown to significantly decrease the …

medicine.medical_specialtyFracture riskEndocrinology Diabetes and MetabolismOsteoporosisIncidence; FRACTURETreatment resistancelaw.inventionCalcium and vitamin D intake Fracture risk Osteoporosis Treatment compliance Treatment resistancecalcium and vitamin d intake; fracture risk; osteoporosis; treatment compliance; treatment resistanceFractures BoneRandomized controlled trialRisk FactorslawInternal medicineCalcium and vitamin D intakemedicineVitamin D and neurologyHumansOrthopedics and Sports MedicineRaloxifeneVitamin DAgedRetrospective StudiesAlendronateBone Density Conservation Agentsbusiness.industryIncidenceIncidence (epidemiology)Etidronic AcidRetrospective cohort studyMiddle Agedmedicine.diseaseCalcium and vitamin D intake Fracture incidence Fracture risk Osteoporosis Treatment compliance Treatment resistanceFRACTUREFracture incidenceSurgeryItalyRaloxifene HydrochlorideRisedronic acidOsteoporosisFemaleObservational studyTreatment compliancebusinessRisedronic Acidmedicine.drug
researchProduct

FokI Polymorphism of the Vitamin D Receptor Gene Correlates with Parameters of Bone Mass and Turnover in a Female Population of the Italian Island of…

2005

One of the most promising genetic approaches to dissecting a multifactorial disease is represented by genetically isolated population studies. We studied a genetic marker in a cohort of women living on the Mediterranean island of Lampedusa, a geographically isolated population. Lampedusa, located between the African coast and Sicily, consists of a young genetic isolate (<20 generations) with an exponential growth in the last generations. We analyzed the association between the FokI vitamin D receptor (VDR) gene polymorphism, previously proposed as a predictor of bone mass, with parameters of bone mass and turnover in a cohort of pre- and postmenopausal women living on Lampedusa. In 424 wome…

medicine.medical_specialtyGenotypeBone densityEndocrinology Diabetes and MetabolismOsteoporosisCalcitriol receptorBone and BonesWhite PeopleCohort StudiesFokI polymorphism of the vitamin DEndocrinologyGene FrequencyBone DensityRisk FactorsInternal medicineGenotypemedicineHumansOrthopedics and Sports MedicineAllele frequencyOsteoporosis PostmenopausalUltrasonographyPolymorphism GeneticbiologyExonsMiddle Agedmedicine.diseaseFokIPostmenopauseEndocrinologyItalyPremenopauseOsteocalcinbiology.proteinReceptors CalcitriolFemaleGene polymorphismCalcified Tissue International
researchProduct

The COMT val158met Polymorphism Is Associated with Early Pubertal Development, Height and Cortical Bone Mass in Girls

2005

Estrogens are involved in accretion of bone mass during puberty. Catechol-O-Methyltransferase (COMT) is involved in the degradation of estrogens. In this cross-sectional study we investigated associations between the COMT val158met polymorphism, which results in a 60-75% difference in enzyme activity between the val (high activity = H) and the met (low activity = L) variant, and skeletal phenotypes in 246 healthy pre/early pubertal girls. Girls with COMT(LL) were 5.4 cm taller than COMT(HH) girls. Dual x-ray absorptiometry showed higher values of bone mineral content (BMC), and larger areas of total body, femur and spine in COMT(LL). Cortical BMC, measured by peripheral quantitative compute…

medicine.medical_specialtyGenotypeBone densitymedicine.medical_treatmentCatechol O-Methyltransferasebehavioral disciplines and activitiesBone and BonesInsulin-like growth factorAbsorptiometry PhotonMethionineBone DensityInternal medicinemental disordersGenotypemedicineHumansFemurTibiaChildBone mineralPolymorphism GeneticCatechol-O-methyl transferaseEstradiolbusiness.industryPubertyfungiEstrogensValineBody HeightPhenotypemedicine.anatomical_structureEndocrinologynervous systemPediatrics Perinatology and Child HealthBody CompositionRegression AnalysisFemaleCortical boneTomography X-Ray ComputedbusinessPediatric Research
researchProduct

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Prot…

2021

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating condition. To date, no specific studies have prospectively evaluated the efficacy of its treatment and no robust standard of care has been established. Therefore, a systematic review (2007–2020) with a pooled analysis was performed in order to compare MRONJ surgical techniques (conservative or aggressive) versus combined surgical procedures (surgery plus a non-invasive procedure), where 1137 patients were included in the pooled analysis. A statistically significant difference in the 6-month improvement rate, comp…

medicine.medical_specialtyHealth Toxicology and Mutagenesismedicine.medical_treatmentONJReviewsurgerymedicineHumansAdverse effectONJ Osteonecrosis Staging Surgery Therapy TreatmenttherapyONJ; Osteonecrosis; Staging; Surgery; Therapy; Treatment; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Humans; Bone Density Conservation AgentsDiphosphonatesBone Density Conservation Agentstreatmentbusiness.industryosteonecrosisSignificant differenceBlood componentRPublic Health Environmental and Occupational HealthstagingSurgical proceduresmedicine.diseaseSurgeryPooled analysisImprovement rateMedicineBisphosphonate-Associated Osteonecrosis of the JawOsteonecrosis of the jawbusinessAdjuvantInternational Journal of Environmental Research and Public Health
researchProduct

Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women.

2002

The purpose of this intervention trial was to determine whether changes in bone mass distribution could be observed in postmenopausal women following hormone replacement therapy (HRT) and/or high-impact physical exercise. Eighty healthy women, aged 50-57 years, at5 years after the onset of menopause and with no previous use of HRT, were randomly assigned to one of four groups: HRT; exercise (Ex); HRT + Ex (ExHRT); and control (Co). HRT administration was conducted in a double-blind manner for 1 year using estradiol plus noretisterone acetate (Kliogest). The exercise groups participated in a 1 year progressive training program consisting of jumping and bounding activities. Subjects participa…

medicine.medical_specialtyHistologyBone diseaseBone densityPhysiologyEndocrinology Diabetes and MetabolismOsteoporosisUrologyPhysical exerciseDouble-Blind MethodBone DensitymedicineHumansTibiaQuantitative computed tomographyExerciseBone mineralAnalysis of Variancemedicine.diagnostic_testEstradiolbusiness.industryEstrogen Replacement TherapyMiddle Agedmedicine.diseaseSurgeryPostmenopauseNorethindrone Acetatemedicine.anatomical_structureCortical boneFemalesense organsNorethindronebusinessBone
researchProduct

Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial.

2003

In this randomized, double-blind, placebo-controlled 12-month trial we evaluated effects of weight- bearing jumping exercise and oral alendronate, alone or in combination, on the mass and structure of bone, risk factors for falling (muscle strength and power, postural sway, and dynamic balance), and cardiorespiratory fitness in postmenopausal women. A total of 164 healthy, sedentary, early postmenopausal women were randomly assigned to one of four experimental groups: (1) 5 mg of alendronate daily plus progressive jumping exercise, (2) 5 mg alendronate, (3) placebo plus progressive jumping exercise, or (4) placebo. The primary endpoint was 12-month change in bone mass and geometry (measured…

medicine.medical_specialtyHistologyBone diseasePhysiologyEndocrinology Diabetes and MetabolismOsteoporosisUrologyPhysical exerciseBone remodelingDouble-Blind MethodBone DensityRisk FactorsmedicineConfidence IntervalsHumansExercise physiologyExerciseFemoral neckLumbar VertebraeAlendronatebusiness.industryFemur NeckAlendronic acidMiddle Agedmedicine.diseaseSurgeryPostmenopausemedicine.anatomical_structureCortical boneFemaleBone Remodelingbusinessmedicine.drugBone
researchProduct

Étienne Destot (1864–1918) : l’anatomie radiographique

2014

Destot was born in Dijon, France, in 1864. He began his education in Burgundy, then he started his preclinical curriculum in Lyon, France, from 1884. He had to leave Lyon, and spent some times in Algeria to treat a tuberculosis. He came back in Lyon as a resident in 1886. Destot worked as an assistant in the laboratory of anatomy of Leo Testut in 1880. His thesis, in 1892, analyzed mortality in the departments of surgery of the Lyon hospitals. The polemical results he presented compromised his surgical career. He went on as prosector by Leo Testut, and then became electrician-physician in 1895 (electrotherapy and galvanotherapy). Etienne Destot of Lyon, France, developed in 1895 the first r…

medicine.medical_specialtyHistoryGeneral surgeryTraumatologyWristMalleolusmedicine.anatomical_structureScaphoid boneTarsus (skeleton)ProsectormedicineCalcaneusAnatomyAnkleMorphologie
researchProduct